Company intelligence / Profile preview

Bright Moon Seaweed Group

Qingdao, Shandong, Chinabmsg.com ↗

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

The company has over five decades of experience in large-scale seaweed processing. It leads globally in the production of alginates and sugar alcohols for food, pharma excipient/API use, personal care/cosmetics ingredients, marine biomedical materials for wound dressings/absorbents/nonwovens. Its products are widely exported and certified to GMP/BRC/FDA/ISO standards[1][2][3][4].

Modalities: Biologic (marine biopolymers such as alginate, chitosan, fucoidan)Small molecule (mannitol, sorbitol—sugar alcohols used as excipients and APIs)Protein (seaweed biological enzyme products)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Bright Moon Seaweed Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bright Moon Seaweed Group.

Explore the full profile